Can Wellbutrin Cause Hallucinations?
Yes, Wellbutrin (bupropion) can cause hallucinations, though this is an uncommon but serious adverse effect that requires immediate discontinuation of the medication.
Evidence from FDA Drug Labeling
The FDA-approved prescribing information explicitly warns that patients may experience "unusual thoughts or behaviors while taking Wellbutrin XL, including delusions (believe you are someone else), hallucinations (seeing or hearing things that are not there), paranoia (feeling that people are against you), or feeling confused" 1. The drug label specifically instructs patients to call their healthcare provider if these symptoms occur.
In overdose situations, the FDA label documents that hallucinations are among the serious reactions reported with bupropion overdoses, along with loss of consciousness, mental status changes, and seizures 1.
Clinical Evidence and Context
Hallucinations at Therapeutic Doses
While the NCCN smoking cessation guidelines 2 emphasize monitoring for neuropsychiatric issues (depression, suicidal ideation/behavior), they do not specifically highlight hallucinations as a common concern at standard doses. However, case reports demonstrate this can occur:
- Visual and auditory hallucinations have been documented in patients receiving therapeutic doses of bupropion, particularly in those with bipolar disorder or predisposition to psychosis 3
- The mechanism likely involves bupropion's dopaminergic effects through inhibition of dopamine reuptake 3, 4
Hallucinations in Overdose
The risk becomes substantially higher with overdose:
- In a retrospective review of 385 intentional bupropion overdoses, hallucinations were among the prominent effects alongside tachycardia, agitation, and seizures 5
- A case report documented a 14-year-old who developed hallucinations and tachycardia after ingesting only 1,500 mg 6
- Bupropion toxicity can present with auditory and visual hallucinations that may mimic other conditions like alcohol withdrawal syndrome 7
Risk Factors and Clinical Considerations
Higher-risk populations include:
- Patients with preexisting psychotic symptoms or bipolar disorder 3, 4
- Those taking higher doses of bupropion 4
- Patients with substance abuse history 4
- Those with drug interactions that may increase bupropion levels 3
Important caveats:
- The large EAGLES trial (n=8,144) examining neuropsychiatric safety found that bupropion did not significantly increase neuropsychiatric adverse events compared to placebo or nicotine patches in either psychiatric or non-psychiatric populations 2, 8. However, this trial focused on depression and suicidal ideation rather than specifically tracking hallucinations
- Concurrent use of antipsychotics at adequate doses appears protective 4
Clinical Management Algorithm
If hallucinations occur:
- Immediately discontinue bupropion - this is the primary intervention 1
- Provide supportive care and close monitoring
- Rule out overdose (check serum bupropion and hydroxybupropion levels if available) 7, 9
- Consider alternative diagnoses that may present similarly
- Do not restart bupropion in patients who develop hallucinations
Prevention:
- Screen for history of psychotic symptoms before prescribing
- Avoid doses exceeding 300 mg/day (maximum recommended dose) 2
- Monitor closely during dose escalation
- Educate patients and families to report unusual perceptual experiences immediately
The bottom line: while hallucinations are not a common side effect at therapeutic doses, they represent a serious adverse reaction that mandates immediate cessation of bupropion and should be considered in any patient on this medication presenting with new perceptual disturbances.